# Uncoupling Metastasis and Epithelial‐to‐Mesenchymal Transition in sgP19/kRAS‐Driven Spontaneous Metastatic Liver Tumor Model

**Authors:** Jingwen Wang, Zijing Xu, Lei Xu, Lishan Wang, Jiahao Geng, Xue Wang, Meng Xu, Daphne Superville, Melissa Reeves, Matthias Evert, Diego F. Calvisi, Xin Chen, Xinhua Song

PMC · DOI: 10.1002/advs.202514198 · Advanced Science · 2025-12-07

## TL;DR

This study shows that EMT, a process linked to cancer spread, does not drive metastasis in a specific liver cancer model, challenging its role in tumor progression.

## Contribution

The first murine model of iCCA with 100% spontaneous metastasis and evidence that EMT does not influence tumor development or metastasis.

## Key findings

- A murine iCCA model with 100% spontaneous metastasis was developed.
- EMT induced by TGFβ/ZEB1 does not affect tumor development or metastasis.
- Both epithelial and mesenchymal tumor cells coexist in the model.

## Abstract

Epithelial‐to‐mesenchymal transition (EMT) is an early event during tumor metastasis. Here, the relevance of EMT in liver carcinogenesis and metastasis is sought to be determined in a murine mixed typical intrahepatic cholangiocarcinoma (iCCA)/sarcomatoid iCCA liver tumor model using CRISPR/Cas9‐based gene deletion of p19 (sgP19) in combination with transposon‐based expression of the activated form of pCaggs‐kRASG12D (kRAS) in the mouse liver (sgP19/kRAS mixed model). It discovered that metastasis in the lymph node, lung, or kidney occurred in the sgP19/kRAS mixed model. Both typical iCCA tumor cells with epithelial features and sarcomatoid tumor cells with mesenchymal features could be detected in this model. Lineage tracing technology is applied to confirm the metastasis induced in the sgP19/kRAS model. Subsequently, the gain of expression of mesenchymal marker vimentin in tumor cells revealed the induction of EMT in the sgP19/kRAS model, and it is induced by activating the TGFβ/ZEB1 signaling pathway. Altogether, the study suggests that TGFβ/ZEB1 mediates the induction of EMT in iCCA, while targeting EMT failed to inhibit iCCA development or tumor metastasis, disputing the claims that EMT is a major molecular event leading to tumor metastasis.

The article first reported that a murine mixed typical intrahepatic cholangiocarcinoma (iCCA)/sarcomatoid iCCA liver tumor model with 100% incidence of spontaneous extrahepatic metastasis and confirmed the occurrence of in mouse iCCA. Most importantly, EMT induced by the TGF‐β/ZEB1 axis does not influence tumor development or distant metastasis in this model.

## Linked entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845], PRELID1 (PRELI domain containing 1) [NCBI Gene 737446], ZEB1 (zinc finger E-box binding homeobox 1) [NCBI Gene 6935]
- **Proteins:** TGFB1 (transforming growth factor beta 1)
- **Diseases:** intrahepatic cholangiocarcinoma (MONDO:0003210)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Zeb1 (zinc finger E-box binding homeobox 1) [NCBI Gene 21417] {aka 3110032K11Rik, AREB6, BZP, MEB1, Nil2, TCF-8}, Vim (vimentin) [NCBI Gene 22352]
- **Diseases:** tumor (MESH:D009369), liver carcinogenesis (MESH:D063646), Liver Tumor (MESH:D008113), Metastasis (MESH:D009362), sarcomatoid (MESH:D002292), iCCA (MESH:D018281)
- **Chemicals:** sgP19 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12884727/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12884727/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12884727/full.md

---
Source: https://tomesphere.com/paper/PMC12884727